MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2
ConclusionsOur results suggest that miR-155-5p facilitates tumor progression of OSCC by targeting ARID2, and miR-155-5p-ARID2 axis may be a potential therapeutic target of OSCC.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Epithelial Cancer | Genetics | Men | Molecular Biology | Oral Cancer | Skin Cancer | Squamous Cell Carcinoma | Study